The investigator-sponsored phase I trial is being conducted at Cedars-Sinai Medical Center in Los Angeles, CA, by Jeremy Rudnick, MD, and ImmunoCellular is supporting the trial by providing the ICT-121 vaccine.
http://eon.businesswire.com/news/eon/20130730005561/en/ImmunoCellular-Therapeutics-Announces-Initiation-Phase-Trial-Cancer
http://eon.businesswire.com/news/eon/20130730005561/en/ImmunoCellular-Therapeutics-Announces-Initiation-Phase-Trial-Cancer
No comments:
Post a Comment